Eric Bourbonnais

Opportunities for the Canadian Light Utility Vehicle (LUV) procurement using Canadian made steel to support domestic jobs and manufacturing. New opportunities for Canadian defence procurements and other buy Canadian opportunities such as infrastructure and transportation. Potential new policies, regulations, or international agreements impacting Canada’s international trade framework, with implications for the steel industry. Federal government priorities and policies related to the international trade of steel and improve the competitiveness of the domestic steel industry. Support measures for steel industry and workers based on domestic economic conditions, increased tariffs, and ongoing global trade issues.

Discussions on measures to support the competitiveness of the Canadian aluminum industry in the current trade climate. Propose changes to the Clean Technology Investment Tax Credit to support green transition projects in the manufacturing sector. Promouvoir le développement de nouvelles technologies de production d'aluminium au Canada. Discussion on the design of potential future carbon border adjustment mechanism in Canada. Discussion on CUSMA implementation and impacts of trade barriers (ie 232 tariffs) for market access to the US of Canadian aluminum Démarche avec le Fonds Stratégique pour l’Innovation concernant le projet de technologie avancée de fusion d’aluminium. Demande de financement pour le développement de nouvelles technologies de production d'aluminium au Canada. Sources de financement à déterminer.

Discussing the value of the subsidiary OmniaBio, as soveriegn capacity that is critical to Canada's needs in the event of future pandemics or national emergency, leading to support from federal entitities that supply capital and other financial products. Continued effort to maintain strong support for strategic value of the Strategic Response Fund support for the project re the application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.

Seeking funding from the Government of BC and from the Federal Government for Project AgriGuard, a major capital infrastructure project in British Columbia. Project AgriGuard is a new, state-of-the-art food byproduct rendering facility in Metro Vancouver designed to safeguard the long-term sustainability of food production in Western Canada.

Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.

Supporting the company in seeking government funding for medical isotope production.

Encourage the development of infrastructure and innovation initiatives that will allow the Canadian agriculture and cereals industries to continue to be world leaders in science-based research and development, while ensuring the maintenance of our competitive export position into the future.

Démarches auprès de différentes instances gouvernementales pour obtenir du financement dans le cadre du développement de projets de partenariat avec la communauté de Uashat Mak Mani-Utenam. Démarches en vue d'identifier et obtenir l’aide financière disponible aux fins d’un projet de croissance à l’usine de bouletage de Pointe-Noire à Sept-Îles Démarches en vue d'identifier et obtenir l’aide financière disponible aux fins de projets de croissance dans la Fosse du Labrador. Démarches visant à promouvoir le rôle stratégique du concentré de fer de haute pureté produit par Champion Iron dans la décarbonation de l’industrie de l’acier. Démarches visant à obtenir les autorisations nécessaires pour le plan de compensation associé au projet d’augmentation de la capacité d’entreposage au site minier du Lac Bloom. Démarches visant à ce que les instances gouvernementales adoptent une orientation pour stimuler des investissements gouvernementaux qui permettraient d’optimiser les infrastructures régionales, faciliter la transformation du minerai de fer au Québec et réduire les émissions de gaz à effet de serre associées aux activités de certaines entreprises de la région de la Côte-Nord. Démarches en vue d’obtenir les permis et autorisations nécessaires dans le cadre des projets de croissance évalués par Champion Iron. Démarches en vue d'identifier et obtenir l’aide financière disponible aux fins d’un projet de croissance au site minier du Lac Bloom.

Démarches pour explorer les opportunités de soutien financier afin de soutenir le programme de recherche et de développement de la technologie de production d'aluminium à anodes inertes d'ELYSIS. Démarches réalisées afin de faire connaître l'avancement du programme de recherche et développement (R&D) de la technologie de production d'aluminium à anodes inertes d'ELYSIS.

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo